These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7571174)

  • 21. [Bilateral renal cell carcinoma: report of a case].
    Kobayashi M; Imai K; Kiren H; Ito Y; Yamanaka H
    Hinyokika Kiyo; 1986 May; 32(5):721-8. PubMed ID: 3751799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer.
    Dillman RO; Beutel LD; Cornforth AN; Nayak SK
    Cancer Biother Radiopharm; 2000 Apr; 15(2):161-8. PubMed ID: 10803321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence rate of satellite tumors in renal cell carcinoma.
    Kinouchi T; Mano M; Saiki S; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
    Cancer; 1999 Dec; 86(11):2331-6. PubMed ID: 10590375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy.
    Rendon RA; Kachura JR; Sweet JM; Gertner MR; Sherar MD; Robinette M; Tsihlias J; Trachtenberg J; Sampson H; Jewett MA
    J Urol; 2002 Apr; 167(4):1587-92. PubMed ID: 11912369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
    Berger M; Frairia R; Piacibello W; Sanavio F; Palmero A; Venturi C; Pignochino Y; Berta L; Madon E; Aglietta M; Fagioli F
    Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytocidal effect of high energy shock wave on tumour cells enhanced with larger dose and multiple exposures.
    Yao CZ; Ishizuka J; Bold RJ; Townsend CM; Thompson JC
    Surg Oncol; 1994 Aug; 3(4):229-35. PubMed ID: 7834114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized medicine for renal cell carcinoma: establishment of primary cell line culture from surgical specimens.
    Kim FJ; Campagna A; Khandrika L; Koul S; Byun SS; vanBokhoven A; Moore EE; Koul H
    J Endourol; 2008 Oct; 22(10):2361-6. PubMed ID: 18937598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.
    Figlin RA; Thompson JA; Bukowski RM; Vogelzang NJ; Novick AC; Lange P; Steinberg GD; Belldegrun AS
    J Clin Oncol; 1999 Aug; 17(8):2521-9. PubMed ID: 10561318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal multifocal carcinoma with adrenal gland metastasis in a patient previously treated with radical nephrectomy: what kind of therapy. Review of the literature].
    Casetta G; De Zan A; Vella R; Moiso A; Tizzani A
    Minerva Urol Nefrol; 1997 Dec; 49(4):215-7. PubMed ID: 9557505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of successive high-energy shock-wave tumor administration on tumor blood flow.
    Cornel EB; Smits GA; Debruyne FM; Heerschap A; Schalken JA; Oosterhof GO
    Ultrasound Med Biol; 1995; 21(2):243-8. PubMed ID: 7571132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of primary renal carcinoma cultures.
    Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
    Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo distribution of recombinant interleukin-2-activated autologous lymphocytes administered by intra-arterial infusion in patients with renal cell carcinoma.
    Morita T; Yonese Y; Minato N
    J Natl Cancer Inst; 1987 Mar; 78(3):441-50. PubMed ID: 3102826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
    Hanak L; Slaby O; Lauerova L; Kren L; Nenutil R; Michalek J
    Med Sci Monit; 2009 Dec; 15(12):CR638-43. PubMed ID: 19946235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
    Märten A; Renoth S; Heinicke T; Albers P; Pauli A; Mey U; Caspari R; Flieger D; Hanfland P; Von Ruecker A; Eis-Hübinger AM; Müller S; Schwaner I; Lohmann U; Heylmann G; Sauerbruch T; Schmidt-Wolf IG
    Hum Gene Ther; 2003 Mar; 14(5):483-94. PubMed ID: 12691613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal cell carcinoma in a patient with malignant lymphoma: a case report].
    Takagi Y; Senda M; Tanaka J
    Hinyokika Kiyo; 2000 Aug; 46(8):545-7. PubMed ID: 11019373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astragalus membranaceus reduces free radical-mediated injury to renal tubules in rabbits receiving high-energy shock waves.
    Sheng BW; Chen XF; Zhao J; He DL; Nan XY
    Chin Med J (Engl); 2005 Jan; 118(1):43-9. PubMed ID: 15642225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of pathological evaluation of morcellated kidneys after radical nephrectomy.
    Landman J; Lento P; Hassen W; Unger P; Waterhouse R
    J Urol; 2000 Dec; 164(6):2086-9. PubMed ID: 11061932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
    Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
    J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.